Comment on: "Monoamine Oxidase Inhibitors (MAOIs) in Psychiatric Practice: How to Use them Safely and Effectively"
CNS Drugs
.
2022 Jan;36(1):101-102.
doi: 10.1007/s40263-021-00881-2.
Epub 2021 Dec 7.
Author
Sven Ulrich
1
Affiliation
1
Medical-Scientific Department, Aristo Pharma GmbH, Wallenroder Straße 8-10, 13435, Berlin, Germany. sven.ulrich@aristo-pharma.de.
PMID:
34874532
DOI:
10.1007/s40263-021-00881-2
No abstract available
Publication types
Letter
Comment
MeSH terms
Depression*
Food-Drug Interactions
Humans
Monoamine Oxidase Inhibitors* / therapeutic use
Substances
Monoamine Oxidase Inhibitors